ID

26122

Descripción

Study ID: 111029 Clinical Study ID: 111029 Study Title: Double-blind, randomized study to evaluate the immunogenicity and reactogenicity of three different lots of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine containing 1440 EL.U of antigen per mL and injected according to a 0, 6 month schedule in healthy adult subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00289757 https://clinicaltrials.gov/ct2/show/NCT00289757 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 4 Study Recruitment Status: Completed Generic Name: Hepatitis A Vaccine, Inactivated Trade Name: Havrix Study Indication: Hepatitis A Documentation part: Study conclusion

Link

https://clinicaltrials.gov/ct2/show/NCT00289757

Palabras clave

Versiones (1)
  1. 9/10/17 9/10/17 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

9 de octubre de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Immunogenicity and reactogenicity of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine Study conclusion 111029

Inglés

Study conclusion Immunogenicity and reactogenicity of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine 111029

1 formularios  
Follow-up Studies
Descripción

Follow-up Studies

Alias
UMLS CUI-1
C1707478
UMLS CUI-2
C0008976
UMLS CUI-3
C0016441
UMLS CUI-4
C0170300
Would the subject be willing to participate in a follow-up study?
Descripción

follow-up study

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0016441
UMLS CUI [1,2]
C2348568
reason for non participation
Descripción

If No, please specify the reason

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0558080
UMLS CUI [1,2]
C0679823
UMLS CUI [1,3]
C0392360
Reason for non participation: Adverse Events, or Serious Adverse Events, please specify
Descripción

reason for non participation

Tipo de datos

text

Alias
UMLS CUI [1]
C0877248
UMLS CUI [2,1]
C0558080
UMLS CUI [2,2]
C0679823
UMLS CUI [2,3]
C0392360
Reason for non participation: Other, please specify
Descripción

reason for non participation

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0558080
UMLS CUI [1,2]
C0679823
UMLS CUI [1,3]
C0392360
Did any elimination criteria become applicable during the study?
Descripción

exclusion criteria

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0680251
Did any elimination criteria become applicable during the study? If Yes, please specify
Descripción

exclusion criteria

Tipo de datos

text

Alias
UMLS CUI [1]
C0680251
Has the subject dropped out of the study?
Descripción

(a drop out is a subject who did not come back for the concluding visit foreseen in the protocol.)

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568
Has the subject dropped out of the study? If Yes, please mark the ONE most appropriate category for drop out.
Descripción

reason for study drop out

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1444662
UMLS CUI [1,2]
C0392360
UMLS CUI [1,3]
C2348568
If Non-Serious adverse event, Please specify AE Number
Descripción

Has the subject dropped out of the study?

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1518404
UMLS CUI [1,2]
C0237753
UMLS CUI [2,1]
C1444662
UMLS CUI [2,2]
C0392360
If Protocol violation, please specify
Descripción

Has the subject dropped out of the study?

Tipo de datos

text

Alias
UMLS CUI [1]
C1709750
UMLS CUI [2,1]
C1444662
UMLS CUI [2,2]
C0392360
If Other, please specify
Descripción

Has the subject dropped out of the study?

Tipo de datos

text

Alias
UMLS CUI [1,1]
C1444662
UMLS CUI [1,2]
C0392360
UMLS CUI [1,3]
C2348568
Date of last contact
Descripción

Date of last contact

Tipo de datos

date

Alias
UMLS CUI [1,1]
C1705415
UMLS CUI [1,2]
C0011008
Was the subject in good condition at date of last contact?
Descripción

subject condition

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1142435
UMLS CUI [1,2]
C0681850
Pregnancy Information
Descripción

Pregnancy Information

Alias
UMLS CUI-1
C0032961
UMLS CUI-2
C1533716
Has the subject become pregnant during the study?
Descripción

pregnant

Tipo de datos

integer

Alias
UMLS CUI [1]
C0032961
Volver a la parte superior de la página

Similar models

Study conclusion Immunogenicity and reactogenicity of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine 111029

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Follow-up Studies
C1707478 (UMLS CUI-1)
C0008976 (UMLS CUI-2)
C0016441 (UMLS CUI-3)
C0170300 (UMLS CUI-4)
follow-up study
Item
Would the subject be willing to participate in a follow-up study?
boolean
C0016441 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
Item
reason for non participation
integer
C0558080 (UMLS CUI [1,1])
C0679823 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
reason for non participation
Code List
reason for non participation
CL Item
Adverse Events, or Serious Adverse Events (1)
CL Item
Other (2)
reason for non participation
Item
Reason for non participation: Adverse Events, or Serious Adverse Events, please specify
text
C0877248 (UMLS CUI [1])
C0558080 (UMLS CUI [2,1])
C0679823 (UMLS CUI [2,2])
C0392360 (UMLS CUI [2,3])
reason for non participation
Item
Reason for non participation: Other, please specify
text
C0558080 (UMLS CUI [1,1])
C0679823 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
exclusion criteria
Item
Did any elimination criteria become applicable during the study?
boolean
C0680251 (UMLS CUI [1])
exclusion criteria
Item
Did any elimination criteria become applicable during the study? If Yes, please specify
text
C0680251 (UMLS CUI [1])
study drop out
Item
Has the subject dropped out of the study?
boolean
C2348568 (UMLS CUI [1])
Item
Has the subject dropped out of the study? If Yes, please mark the ONE most appropriate category for drop out.
integer
C1444662 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C2348568 (UMLS CUI [1,3])
reason for study drop out
Code List
Has the subject dropped out of the study? If Yes, please mark the ONE most appropriate category for drop out.
CL Item
Serious adverse event (complete the Serious Adverse Event form).  (1)
CL Item
Non-Serious adverse event (complete the Non-serious Adverse Event form).  (2)
CL Item
Protocol violation, please specify (3)
CL Item
Consent withdrawal, not due to an adverse event (4)
CL Item
Migrated / moved from the study area  (5)
CL Item
Lost to follow-up (6)
CL Item
Other, please specify (7)
AE Number
Item
If Non-Serious adverse event, Please specify AE Number
integer
C1518404 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
C1444662 (UMLS CUI [2,1])
C0392360 (UMLS CUI [2,2])
Protocol violation,
Item
If Protocol violation, please specify
text
C1709750 (UMLS CUI [1])
C1444662 (UMLS CUI [2,1])
C0392360 (UMLS CUI [2,2])
reason for study drop out
Item
If Other, please specify
text
C1444662 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C2348568 (UMLS CUI [1,3])
Date of last contact
Item
Date of last contact
date
C1705415 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
subject condition
Item
Was the subject in good condition at date of last contact?
boolean
C1142435 (UMLS CUI [1,1])
C0681850 (UMLS CUI [1,2])
Item Group
Pregnancy Information
C0032961 (UMLS CUI-1)
C1533716 (UMLS CUI-2)
Item
Has the subject become pregnant during the study?
integer
C0032961 (UMLS CUI [1])
pregnant
Code List
Has the subject become pregnant during the study?
CL Item
No (1)
CL Item
Yes, please complete the Pregnancy Report Form.  (2)
CL Item
NA (3)
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial